Matches in Nanopublications for { ?s ?p "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP430162.RAMadW8pzK_Hpj6wtd9BUDils0VhLwiUCgbbnc2GgdHKo130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430162.RAMadW8pzK_Hpj6wtd9BUDils0VhLwiUCgbbnc2GgdHKo130_provenance.
- NP737128.RAwbbHaT16vuAFwQ4rgkLHRLHtegDLZoSpf__XsKPZqm4130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737128.RAwbbHaT16vuAFwQ4rgkLHRLHtegDLZoSpf__XsKPZqm4130_provenance.
- NP620939.RAYhaivTHsHpB0uX0gr-7sSLYbBuxWu1JDaFsuBgtNa18130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620939.RAYhaivTHsHpB0uX0gr-7sSLYbBuxWu1JDaFsuBgtNa18130_provenance.
- assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP949929.RAR3_av6az0BXeTIysKvyxLe3oTdYxz7MxpDo1DrZ90BI130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949929.RAR3_av6az0BXeTIysKvyxLe3oTdYxz7MxpDo1DrZ90BI130_provenance.
- NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949930.RAWYIVy-2062QFo_j5dDTTGuTOJh5dSAP9l_WVS4zEqKg130_provenance.
- NP624807.RArSzyananFhToU6EBNNlMYTEtfwjEB9Sw972O5Ls3ApM130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624807.RArSzyananFhToU6EBNNlMYTEtfwjEB9Sw972O5Ls3ApM130_provenance.
- NP623672.RAFCJSqGi54fVAnX3vyQfCPiCe2ZC9J0ckrB7-bqAz5NI130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623672.RAFCJSqGi54fVAnX3vyQfCPiCe2ZC9J0ckrB7-bqAz5NI130_provenance.
- NP622360.RAyy5j1wbT7ZtnLQxITqWA1XEx7dP7hMW7HNwTIM04tIY130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622360.RAyy5j1wbT7ZtnLQxITqWA1XEx7dP7hMW7HNwTIM04tIY130_provenance.
- NP949931.RA5KSiNK6HGzVrVcceGtWFg3blnDU2q_TmzwZSkrOfx9Q130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949931.RA5KSiNK6HGzVrVcceGtWFg3blnDU2q_TmzwZSkrOfx9Q130_provenance.
- NP949933.RA4hMlRLanzcTtSR1anIJA-b5-OD7M1Q1SP_Sa-Xx57Ig130_assertion description "[Our work suggests that dys-regulated protein synthesis and PI3K activity in patient cells might be suitable biomarkers to quantify the efficacy of drugs to ameliorate molecular mechanisms underlying FXS, and could be used for drug screens to refine treatment strategies for individual patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949933.RA4hMlRLanzcTtSR1anIJA-b5-OD7M1Q1SP_Sa-Xx57Ig130_provenance.